Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background:
Ischemic heart disease
(
IHD
) has been the leading cause of death for several decades globally,
IHD
patients usually hold the symptoms of phlegm-stasis cementation syndrome (PSCS) as significant complications. However, the underlying molecular mechanisms of PSCS complicated with
IHD
have not yet been fully elucidated.
Materials and Methods:
Network medicine methods were utilized to elucidate the underlying molecular mechanisms of
IHD
phenotypes. Firstly, high-quality
IHD
-associated genes from both human curated disease-gene association database and biomedical literatures were integrated. Secondly, the
IHD
disease modules were obtained by dissecting the protein-protein interaction (PPI) topological modules in the String V9.1 database and the mapping of
IHD
-associated genes to the PPI topological modules. After that, molecular functional analyses (e.g., Gene Ontology and pathway enrichment analyses) for these
IHD
disease modules were conducted. Finally, the PSCS syndrome modules were identified by mapping the PSCS related symptom-genes to the
IHD
disease modules, which were further validated by both pharmacological and physiological evidences derived from published literatures.
Results:
The total of 1,056 high-quality
IHD
-associated genes were integrated and evaluated. In addition, eight
IHD
disease modules (the PPI sub-networks significantly relevant to
IHD
) were identified, in which two disease modules were relevant to PSCS syndrome (i.e., two PSCS syndrome modules). These two modules had enriched pathways on Toll-like receptor signaling pathway (hsa04620) and Renin-angiotensin system (hsa04614), with the molecular functions of angiotensin maturation (GO:0002003) and response to bacterium (GO:0009617), which had been validated by classical Chinese herbal formulas-related targets,
IHD
-related drug targets, and the phenotype features derived from human phenotype ontology (HPO) and published biomedical literatures.
Conclusion:
A network medicine-based approach was proposed to identify the underlying molecular modules of PSCS complicated with
IHD
, which could be used for interpreting the pharmacological mechanisms of well-established Chinese herbal formulas (
e.g.,
Tao
Hong Si Wu Tang, Dan Shen Yin, Hunag Lian Wen Dan Tang and Gua Lou Xie Bai Ban Xia Tang
). In addition, these results delivered novel understandings of the molecular network mechanisms of
IHD
phenotype subtypes with PSCS complications, which would be both insightful for
IHD
precision medicine and the integration of disease and TCM syndrome diagnoses.
...
PMID:Integrated Modules Analysis to Explore the Molecular Mechanisms of Phlegm-Stasis Cementation Syndrome with Ischemic Heart Disease. 2940 92